MiRNA-146 negatively regulates the production of pro-inflammatory cytokines via NF-κB signalling in human gingival fibroblasts

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Xie, Yu Feng ^a,b   Shu, Rong ^a,b   Jiang, Shao Yun ^a,b   Song, Zhong Chen ^a,b   Guo, Qiu Man ^a,b   Dong, Jia Chen ^a,b   Lin, Zhi Kai ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Research Institute of Stomatology   (China)

Author keywords

Human gingival fibroblasts; MiRNA 146; NF B; Pro inflammatory cytokines

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 146; MICRORNA 146A; MICRORNA 146B; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; GINGIVA; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PHARMACOLOGICAL BLOCKING; PORPHYROMONAS GINGIVALIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84988359657     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-014-0038-z     Document Type: Article

References (29)

1. XQ Q: Report of the third national oral health survey. Beijing: People's Medical Publishing House; 2008:82-104.
2. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998, 95(2):588-593.
3. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2(10):725-734.
4. Gutierrez-Venegas G, Kawasaki-Cardenas P, Cruz-Arroyo SR, Perez-Garzon M, Maldonado-Frias S: Actinobacillus actinomycetemcomitans lipopolysaccharide stimulates the phosphorylation of p44 and p42 MAP kinases through CD14 and TLR-4 receptor activation in human gingival fibroblasts. Life Sci 2006, 78(22):2577-2583.
5. Gutierrez-Venegas G, Castillo-Aleman R: Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts. Int Immunopharmacol 2008, 8(11):1513-1523.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
7. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
8. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5(7):522-531.
9. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103(33):12481-12486.
10. Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA: Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 2009, 583(20):3349-3355.
11. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X: MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183(3):2150-2158.
12. Xie YF, Shu R, Jiang SY, Liu DL, Ni J, Zhang XL: MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm (Lond) 2013, 10(1):20-28.
13. Deguchi S, Ooyama A, Fukuno M, Hori T, Kawase T, Aoki F, Suzuki K, Saito S: [Biochemical characterization of phenytoin-induced hyperplastic human gingival fibroblasts. Non-collagenous proteins biosynthesis]. Nihon Shishubyo Gakkai kaishi 1988, 30(4):1047-1054.
14. Into T, Inomata M, Shibata K, Murakami Y: Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3-and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell Immunol 2010, 264(1):104-109.
15. Javelaud D, Laboureau J, Gabison E, Verrecchia F, Mauviel A: Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem 2003, 278(27):24624-24628.
16. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: Pd-098059 Is a Specific Inhibitor of the Activation of Mitogen-Activated Protein-Kinase Kinase in-Vitro and in-Vivo. J Biol Chem 1995, 270(46):27489-27494.
17. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW, et al: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001, 98(24):13681-13686.
18. Podolin PL, Callahan JF, Bolognese BJ, Li YH, Carlson K, Davis TG, Mellor GW, Evans C, Roshak AK: Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation. J Pharmacol Exp Ther 2005, 312(1):373-381.
19. Stevenson CS, Capper EA, Roshak AK, Marquez B, Grace K, Gerwick WH, Jacobs RS, Marshall LA: Scytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm Res 2002, 51(2):112-114.
20. Powers JP, Li S, Jaen JC, Liu J, Walker NP, Wang Z, Wesche H: Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett 2006, 16(11):2842-2845.
21. Kasperczyk H, La Ferla-Bruhl K, Westhoff MA, Behrend L, Zwacka RM, Debatin KM, Fulda S: Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 2005, 24(46):6945-6956.
22. Akira S: Toll receptor families: structure and function. Semin Immunol 2004, 16(1):1-2.
23. Cook DN, Pisetsky DS, Schwartz DA: Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004, 5(10):975-979.
24. Wang J, Hu Y, Deng WW, Sun B: Negative regulation of Toll-like receptor signaling pathway. Microbes Infect 2009, 11(3):321-327.
25. Quinn SR, O'Neill LA: A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 2011, 23(7):421-425.
26. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA: Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010, 11(2):141-147.
27. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010, 39(4):493-506.
28. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC: Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27(42):5643-5647.
29. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR: Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis. Cancer Res 2009, 69(4):1279-1283.